Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CPRX | Common stock, par value $0.001 per share | Options Exercise | +13.7K | +1.68% | 825K | Feb 15, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CPRX | Restricted Stock Units | Options Exercise | $0 | -13.7K | -0.84% | $0.00 | 1.62M | Feb 15, 2024 | Common Stock | 13.7K | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. |
F2 | Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025. |
F3 | Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on February 15, 2024. |